A detailed history of Fmr LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 6,812,233 shares of ARWR stock, worth $146 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,812,233
Previous 6,394,628 6.53%
Holding current value
$146 Million
Previous $183 Million 3.19%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$21.87 - $28.24 $9.13 Million - $11.8 Million
417,605 Added 6.53%
6,812,233 $177 Million
Q1 2024

May 13, 2024

BUY
$27.21 - $39.48 $82.3 Million - $119 Million
3,023,360 Added 89.68%
6,394,628 $183 Million
Q4 2023

Feb 13, 2024

SELL
$21.2 - $31.03 $19.9 Million - $29.1 Million
-937,635 Reduced 21.76%
3,371,268 $103 Million
Q3 2023

Nov 13, 2023

BUY
$26.2 - $36.08 $41.5 Million - $57.2 Million
1,584,425 Added 58.16%
4,308,903 $116 Million
Q2 2023

Aug 11, 2023

BUY
$25.16 - $41.38 $34 Million - $55.9 Million
1,351,231 Added 98.4%
2,724,478 $97.2 Million
Q1 2023

May 11, 2023

SELL
$23.68 - $38.51 $14.6 Million - $23.7 Million
-616,286 Reduced 30.98%
1,373,247 $34.9 Million
Q4 2022

Feb 13, 2023

SELL
$28.0 - $40.56 $12.9 Million - $18.7 Million
-460,193 Reduced 18.79%
1,989,533 $80.7 Million
Q3 2022

Nov 10, 2022

SELL
$29.63 - $48.31 $8.69 Million - $14.2 Million
-293,242 Reduced 10.69%
2,449,726 $81 Million
Q2 2022

Aug 12, 2022

BUY
$27.79 - $50.61 $37.4 Million - $68 Million
1,344,444 Added 96.13%
2,742,968 $96.6 Million
Q1 2022

May 13, 2022

BUY
$39.62 - $69.97 $1.27 Million - $2.25 Million
32,147 Added 2.35%
1,398,524 $64.3 Million
Q4 2021

Feb 14, 2022

BUY
$58.09 - $82.51 $2.05 Million - $2.91 Million
35,254 Added 2.65%
1,366,377 $90.6 Million
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $2.76 Million - $4.01 Million
47,194 Added 3.68%
1,331,123 $83.1 Million
Q2 2021

Aug 13, 2021

BUY
$62.15 - $90.32 $79.8 Million - $116 Million
1,283,929 New
1,283,929 $106 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.26B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.